University of Southern California at ASH 2026
Dec 12–15, 2026 New Orleans, LA ~30k attendees Website
University of Southern California brings 4 presentations to ASH 2026 in New Orleans. Its program spans rare blood conditions, CAR-T and hemophilia costs. Work covers dual BCMA and GPRC5D in vivo CAR-T, an expert consensus on cold agglutinin disease and marstacimab costs.
| Organization | ASH 2026 Attendance |
|---|---|
University of Southern California Los Angeles, CA | |
Private research university in Los Angeles with the Keck School of Medicine and the Norris cancer center. | Symposium Fri Dec 11 3:00pm–6:00pm Acknowledging the Rare: Navigating Diagnostic and Therapeutic Complexities in Rare Hematologic Disorders Speeding diagnosis and easing treatment burden in idiopathic multicentric Castleman disease, cold agglutinin disease, and immune thrombocytopenia. Talk Fri Dec 11 3:10pm–3:55pm Poster Sat Dec 12 5:30pm–7:30pm Poster Mon Dec 14 6:00pm–8:00pm Poster Mon Dec 14 6:00pm–8:00pm |
Find decision makers at University of Southern California
Tell us what you sell and we’ll find the people at University of Southern California most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction